Dotti
Dotti is Amneal's branded generic of Vivelle-Dot, among the smallest patches sold. Amneal also sells it without the brand name under the same approval.
ASHP lists Dotti 0.0375 mg and 0.1 mg as on back order, with Amneal unable to estimate a release date. The 0.025, 0.05 and 0.075 mg strengths are listed as available. Amneal has said the patches are "complex dosage forms" made with "finite industry capacity" (CNN).
- Made by
- Amneal
- Changed
- Twice a week
- Strengths
- 0.025 mg, 0.0375 mg, 0.05 mg, 0.075 mg, 0.1 mg
- FDA approval
- ANDA 211293
- Medfinder in-stock rate
- 1% of 2,389 checks
Status by strength
| Patch | 0.025 mg | 0.0375 mg | 0.05 mg | 0.075 mg | 0.1 mg |
|---|---|---|---|---|---|
| DottiAmneal · twice a week | Available | Short | Available | Available | Short |
- Available
- Limited
- Short
- Discontinued
- No data
Statuses checked October 18, 2026 against each row's source. We re-check every week.
Each strength in detail
0.025 mg (available) · 0.0375 mg (short) · 0.05 mg (available) · 0.075 mg (available) · 0.1 mg (short)
Any change of brand, strength or form is a decision for your prescriber, and your pharmacist can check what they can order.
Get one email when your strength is back
Pick the strength on your box. When ASHP, the makers or Drug Shortages Canada list it as back in normal supply, we write once with what changed.
Sources
- Dotti label, DailyMed, Amneal, May 14, 2024.
- Drug Shortage Detail: Estradiol Transdermal System, ASHP, August 12, 2026.
- Estrogen patch shortage, CNN, February 23, 2026.
- Estradiol shortage tracker, Medfinder, October 18, 2026.
- Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (data files), FDA, October 9, 2026.